CV vs BFLY vs CBLL Stock Comparison

CapsoVision, Butterfly Network and Ceribell Prices as of Oct 26, 2026 Peers: Industry group
CV CapsoVision, Inc
$6.89 +3.6% 1M +40.6% 1Y
Market cap
$337.08M
P/E
–
Revenue (TTM)
$14.41M
Div. yield
–
Diagnostic Equipment Healthcare
BFLY Butterfly Network, Inc.
$6.65 -29.2% 1M +198.2% 1Y
Market cap
$1.93B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
CBLL Ceribell, Inc.
$27.03 +14.1% 1M +109.7% 1Y
Market cap
$1.03B
P/E
–
Revenue (TTM)
$101.96M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins

Head to Head

6 decided of 12

Butterfly Network leads on 3 of the 12 questions below (Butterfly Network 3, Ceribell 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCVBFLYCBLLLeader
Larger companyMarket capitalisation $337.08M $1.93B $1.03B BFLY
Cheaper on earningsLower P/E, profitable companies only -12.3x -25.8x -15.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months +14.6% +28.1% +31.7% CBLL
More profitableNet margin, trailing twelve months -190.2% -66.7% -64.7% CBLL
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — 1.6x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +40.6% +198.2% +109.7% BFLY
Better 5-year returnAnnualised price return, 5 years — -8.0%/yr — –
Less volatileAnnualised volatility, 1 year 96.1% 114.6% 52.2% CBLL
Higher overall scoreMean of the five percentile scores vs peers 36/100 44/100 38/100 BFLY

Percentile Scorecard

CVBFLYCBLL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCVBFLYCBLL
Valuation 5 #217 of 228 29 #163 of 228 21 #180 of 228
Growth 42 #128 of 221 68 #72 of 221 21 #175 of 221
Profitability 23 #161 of 208 31 #143 of 208 37 #132 of 208
Financial Health 76 #59 of 239 60 #96 of 239 81 #46 of 239
Shareholder Returns – 35 #90 of 137 29 #97 of 137
Overall 36 44 38
  • CV ranked among 248 companies in Medical Devices and Diagnostics
  • BFLY ranked among 248 companies in Medical Devices and Diagnostics
  • CBLL ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCVBFLYCBLLSPY
1 month +3.6%-29.2%+14.1% -0.8%
3 months +4.2%-6.2%+49.1% +3.5%
6 months +8.2%+21.4%+27.9% +7.0%
Year to date -35.5%+75.0%+23.3% +12.2%
1 year +40.6%+198.2%+109.7% +13.0%
3 years —+741.8%— +86.3%
3 years, per year —+103.5%— +23.1%
5 years —-34.2%— +68.6%
5 years, per year —-8.0%— +11.0%

Risk

MeasureCVBFLYCBLLSPY
Volatility, 1Y 96.1%114.6%52.2% 12.7%
Downside volatility, 1Y 89.7%91.7%49.5% 12.7%
Beta vs S&P 500, 1Y 0.622.971.21 1.00
Return / volatility, 1Y 0.421.732.10 1.02
Max drawdown, 5Y -67.8%-93.4%-63.9% -25.4%
From 52-week high -52.2%-33.1%-2.3% -1.8%
52-week high $14.42$9.94$27.68 $779.14
52-week low $4.59$1.97$10.92 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCVBFLYCBLL
P/E now vs peer median -12.5xmedian 30.6x -23.3xmedian 30.6x -15.6xmedian 30.6x
P/S now vs peer median 23.9xmedian 3.0x 14.1xmedian 3.0x 10.1xmedian 3.0x
EV/EBITDA now vs peer median -12.5xmedian 17.5x -20.2xmedian 17.5x -13.5xmedian 17.5x
P/FCF now vs peer median —median 23.3x -56.4xmedian 23.3x -18.9xmedian 23.3x
P/B now vs peer median 26.2xmedian 2.4x 8.4xmedian 2.4x 8.1xmedian 2.4x
PEG now vs peer median —median 0.87 -0.86median 0.87 —median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCVBFLYCBLL
Revenue $14.41M $112.15M $101.96M
Gross profit $7.55M $59.04M $90.65M
Operating income -$27.71M -$79.38M -$69.97M
Net income -$27.42M -$74.85M -$66.00M
Free cash flow – -$28.04M -$54.72M
R&D $20.51M $38.10M $22.95M
EPS (diluted) $-0.55 $-0.29 $-1.74
Cash & equivalents – $124.66M $32.66M
Total debt – – $19.98M
Shares (diluted) 49.94M 262.10M 38.03M
Enterprise value $337.08M $1.38B $436.22M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCVBFLYCBLL
P/E -12.5x -23.3x -15.6x
P/FCF – -56.4x -18.9x
P/Operating cash flow – -65.9x -19.1x
P/S 23.9x 14.1x 10.1x
P/B 26.2x 8.4x 8.1x
P/Tangible book 26.2x 8.7x 8.1x
EV/EBITDA -12.5x -20.2x -13.5x
EV/EBIT -12.4x -18.4x -13.2x
EV/Revenue 23.9x 13.0x 9.1x
EV/FCF – -52.0x -16.9x
EV/Operating cash flow – -60.7x -17.1x
PEG (3Y EPS CAGR) – -0.86 –

Growth

14 metrics
MetricCVBFLYCBLL
Revenue growth (1Y) 14.6% 28.1% 31.7%
Revenue CAGR (3Y) – 15.6% –
Gross profit growth (1Y) 11.1% 8.8% 33.4%
Gross profit CAGR (3Y) – 13.3% –
Operating income growth (1Y) -36.1% -14.8% -34.6%
Operating income CAGR (3Y) – 21.1% –
Net income growth (1Y) -34.9% -19.1% -33.6%
Net income CAGR (3Y) – 20.8% –
EPS growth (1Y) 93.8% -12.9% -27.5%
EPS CAGR (3Y) – 27.0% –
Operating cash flow growth (1Y) – 19.6% -44.3%
Operating cash flow CAGR (3Y) – 44.5% –
Free cash flow growth (1Y) – 12.2% -41.8%
Free cash flow CAGR (3Y) – 42.8% –

Profitability

14 metrics
MetricCVBFLYCBLL
Gross margin 52.4% 52.6% 88.9%
EBITDA margin -190.7% -64.4% -67.1%
Operating margin -192.3% -70.8% -68.6%
Pretax margin -190.1% -66.7% -64.7%
Net margin -190.2% -66.7% -64.7%
FCF margin – -25.0% -53.7%
Operating cash flow margin – -21.4% -53.0%
Return on equity -207.5% -39.3% -49.0%
Return on assets -149.3% -26.3% -38.3%
Return on invested capital – – –
Return on capital employed -209.8% -35.1% -45.1%
Asset turnover 0.8x 0.4x 0.6x
Cash conversion (OCF / net income) – 0.3x 0.8x
Stock comp / revenue – 21.3% 16.1%

Financial Health

11 metrics
MetricCVBFLYCBLL
Debt / assets – – 12.0%
Debt / equity – – 0.2x
Net debt / EBITDA – – 1.6x
Debt / FCF – – -0.4x
Liabilities / assets 29.1% 33.1% 22.9%
Equity / assets 70.9% 66.9% 77.1%
Interest coverage – -59.4x -38.6x
Current ratio 3.4x 4.1x 9.2x
Quick ratio – 2.7x 8.6x
Cash ratio – 2.1x 7.5x
Altman Z-score 22.08 5.90 14.35

Shareholder Returns

7 metrics
MetricCVBFLYCBLL
Dividend yield – – –
Net buyback yield – -0.5% -0.6%
Shareholder yield 0.0% -0.5% -0.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCVBFLYCBLL
EPS, next fiscal year $-0.58FY2026 $-0.10FY2026 $-1.86FY2026
Revenue, next fiscal year $13.91MFY2026 $114.50MFY2026 $118.32MFY2026
Revenue growth, next FY +2.7%FY2026 +17.3%FY2026 +32.9%FY2026
Revenue growth, the year after +46.0% +26.0% +21.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCVBFLYCBLL
Held by institutions 10.2% 59.9% 79.9%
Institutions holding 50 245 124
Change in shares held, QoQ +27.6% +13.9% +2.2%
Institutions buying 36 143 74
Institutions selling 8 59 36
Buyers to sellers 4.50 2.42 2.06

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CVBFLYCBLL
CV 1.00 0.07 0.09
BFLY 0.07 1.00 0.37
CBLL 0.09 0.37 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CV, BFLY and CBLL?

Butterfly Network (BFLY) is the largest by market capitalisation: CapsoVision (CV) $337.08M, Butterfly Network (BFLY) $1.93B, Ceribell (CBLL) $1.03B.

Which company is growing faster?

Ceribell (CBLL) grew revenue fastest over the trailing twelve months: CapsoVision (CV) +14.6%, Butterfly Network (BFLY) +28.1%, Ceribell (CBLL) +31.7%.

Which company is more profitable?

Ceribell (CBLL) has the highest net margin (CapsoVision (CV) -190.2%, Butterfly Network (BFLY) -66.7%, Ceribell (CBLL) -64.7%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: CapsoVision (CV) +40.6%, Butterfly Network (BFLY) +198.2%, Ceribell (CBLL) +109.7%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Ceribell (CBLL) has been the steadiest (CapsoVision (CV) 96.1%, Butterfly Network (BFLY) 114.6%, Ceribell (CBLL) 52.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CV, BFLY and CBLL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.